| Company Name: |
Chembest Research Laboratories Limited
|
| Tel: |
021-20908456 |
| Email: |
sales@BioChemBest.com |
| Products Intro: |
Product Name:3,23-Dioxo-9,19-cyclolanost-24-en-26-oic acid
CAS:870456-88-5
Remarks:C12831
|
| Company Name: |
BioBioPha Co., Ltd.
|
| Tel: |
0871-65217109 13211707573; |
| Email: |
y.liu@mail.biobiopha.com |
| Products Intro: |
Product Name:3,23-Dioxocycloart-24-en-26-oic acid
CAS:870456-88-5
Package:5mg Remarks:BBP00270
|
| Company Name: |
Sichuan Wei Keqi Biological Technology Co., Ltd.
|
| Tel: |
028-81700200 18116577057 |
| Email: |
3003855609@qq.com |
| Products Intro: |
Product Name:(24E)-323-Dioxo-919-cyclolanost-24-en-26-oicacid
CAS:870456-88-5
Purity:98% Package:5mg；10mg；20mg；50mg；100mg；200mg；500mg；1g
|
| Company Name: |
Wuhan ChemFaces Biochemical Co., Ltd.
|
| Tel: |
18607101326 15172504745 |
| Email: |
aileen@chemfaces.com |
| Products Intro: |
Product Name:3,23-Dioxo-9,19-cyclolanost-24-en-26-oic acid
CAS:870456-88-5
Purity:>=98% Package:5mg ,10mg ,20mg ,50mg ,100mg; 200mg; 500mg or according to customer requirements
|
|
| | 3,23-Dioxo-9,19-cyclolanost-24-en-26-oic acid Basic information |
| Product Name: | 3,23-Dioxo-9,19-cyclolanost-24-en-26-oic acid | | Synonyms: | 3,23-Dioxo-9,19-cyclolanost-24-en-26-oic acid;3,23-Dioxocycloart-24-en-26-oic acid;(24E)-3,23-Dioxo-9,19-cyclolanost-24-en-26-oic acid;19-cyclolanost-24-en-26-oic acid;23-Dioxo-9;9,19-Cyclolanost-24-en-26-oic acid, 3,23-dioxo-, (24E)- | | CAS: | 870456-88-5 | | MF: | C30H44O4 | | MW: | 468.67 | | EINECS: | | | Product Categories: | | | Mol File: | 870456-88-5.mol |  |
| | 3,23-Dioxo-9,19-cyclolanost-24-en-26-oic acid Chemical Properties |
| solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | | form | Powder |
| | 3,23-Dioxo-9,19-cyclolanost-24-en-26-oic acid Usage And Synthesis |
| Description | 3,23-Dioxo-9,19-cyclolanost-24-en-26-oic acid inhibits the MRCKα kinase with Kd50 of 3.0 uM, it also inhibits the MRCKβ kinase with Kd50 of 3.2 uM; the role of Kinases in cancer onset and progression has made kinases a target for the control of some cancers, suggests that it may possess anticancer activity. |
| | 3,23-Dioxo-9,19-cyclolanost-24-en-26-oic acid Preparation Products And Raw materials |
|